Navigation Links
Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008
Date:2/25/2009

egulus Therapeutics

Regulus' revenue for the year ended December 31, 2008 was $2.1 million compared to $119,000 in 2007. The increase was primarily related to revenue from its collaboration with GSK.

Excluding non-cash compensation expense related to stock options, operating expenses for Regulus were $7.6 million for the year ended December 31, 2008 compared to $612,000 in 2007. With the strategic alliance with GSK, it is anticipated that Regulus' expenses will increase over its run rate in 2008 as Regulus advances its research and development activities. Regulus generated a loss from operations, excluding non-cash compensation expense related to stock options, of $5.5 million for the year ended December 31, 2008 compared to $493,000 in 2007.

Business Highlights

"Our pipeline has matured significantly in the past year. Together with our partner, Genzyme, we initiated four new studies that will expand our experience with mipomersen. Mipomersen continues to be well tolerated, and our level of confidence with mipomersen's safety profile continues to grow as our clinical and preclinical experience increases. In addition, our partners have reported encouraging clinical data on a number of antisense drugs in our pipeline, including OGX-011 in patients with prostate cancer and ATL/TV1102 in patients with multiple sclerosis. Positive clinical results for the drugs in our pipeline increase the value of all the drugs and add to a growing body of evidence demonstrating the therapeutic benefit of antisense drugs in a variety of diseases. The efficiency of our antisense technology enables us to expand ours and our partner's pipelines with promising new therapies. Furthermore, our strong financial position provides us the freedom to pursue additional therapeutic areas where we feel antisense can offer new treatment options," added Ms. Parshall.

"We believe that we have j
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Lehigh Valley-Based PPO, Valley Preferred, Reports Marked Improvement in Disease Management & Wellness Outcomes
2. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
3. Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results
4. ev3 Inc. Reports 2008 Fourth Quarter and Full-Year Financial Results and 2009 Guidance
5. Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
6. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2008
7. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
8. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
9. 1 in 10 Ex-NFL Players Used Steroids, Poll Reports
10. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
11. Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... May 03, 2015 As one of ... the prestigious Safety and Health Achievement and Recognition Program ... to be chosen by the Illinois Department of Labor ... achieved and maintained SHARP certification by the Occupational Safety ... as Essentra has continued to meet or exceed all ...
(Date:5/2/2015)... Vancouver fencing company, QS Fencing, has recently announced ... prospective clients related to their questions on railings and gates. ... their decks and patios. While that seems like an easy ... the person rolls up their sleeve to start working. One ... finding a gate that matches it. , Instead of spending ...
(Date:5/2/2015)... Aliso Viejo, CA (PRWEB) May 02, 2015 ... made exclusively for use in Final Cut Pro X. ... ready for use in Final Cut Pro X . ... a single keyframe with Pixel Film Studios' ProText Kinetic 2. ... drop. Start by staggering two ProText Kinetic presets in ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 We are ... The Delray Recovery Center as one of the Top ... known in the addiction treatment field for their ethics ... to innovate and to continue their educational efforts. The ... workplace environment, never forgetting their purpose – to help ...
(Date:5/2/2015)... On Tuesday April 7th, the patient ... to celebrate improvements in patient care. In 2014 the ... had zero acquired ventilator associated infections, zero central line ... was also recently named a Top Performer by the ... credited the teamwork of staff from all departments involved ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
... Medicare ... ... -- If you’re one of the more than 45 million people relying on Medicare for ... is too expensive, according to Allsup , a nationwide provider of Social Security disability ...
... , , , ... NXTM ), a leading manufacturer of innovative dialysis products, today ... Chief Financial Officer, will be presenting at the UBS Global Life ... Grand Central in New York City. , , ...
... , , BIRMINGHAM, Ala., ... leader in radiology optimization solutions that increase business capacity, productivity ... its Board of Directors has approved changing its name to ... its ability to more accurately represent the precision imaging management ...
... , , FRANKLIN LAKES, N.J., Sept. 1 BD ... that it would present at the following investor healthcare conferences in September: , , ... September 9, 2009, 10:55 ... September 14, 2009, ...
... rank facilities don,t take all measurements into account , TUESDAY, ... onto the U.S. News & World Report list ... in some measurements regarding heart failure, researchers say. , "If ... the areas of heart failure mortality and readmission, you should ...
... , PISCATAWAY, N.J., Sept. 1 Milestone ... advanced injection technologies, today announced that Leslie Bernhard, an independent ... Osser who had previously led the Company as Chairman since ... Chief Executive Officer since February 2009 and was formerly Milestone,s ...
Cached Medicine News:Health News:Allsup Outlines 10 Critical Questions to Answer When Evaluating Medicare Plans 2Health News:Allsup Outlines 10 Critical Questions to Answer When Evaluating Medicare Plans 3Health News:Allsup Outlines 10 Critical Questions to Answer When Evaluating Medicare Plans 4Health News:Allsup Outlines 10 Critical Questions to Answer When Evaluating Medicare Plans 5Health News:NxStage to Present at the UBS Global Life Sciences Conference 2Health News:Optimal Readings Completes Strategic Name Change to Optimal IMX 2Health News:Optimal Readings Completes Strategic Name Change to Optimal IMX 3Health News:Optimal Readings Completes Strategic Name Change to Optimal IMX 4Health News:Optimal Readings Completes Strategic Name Change to Optimal IMX 5Health News:Optimal Readings Completes Strategic Name Change to Optimal IMX 6Health News:Government Best Source for U.S. Hospital Data, Study Finds 2Health News:Milestone Scientific Announces Key Leadership Changes 2Health News:Milestone Scientific Announces Key Leadership Changes 3
(Date:5/1/2015)... Calif. , May 1, 2015 The ... its 2015 health literacy award winners. The IHA Health ... that make an impact on the practice of educating ... health literacy. IHA gives awards in three categories: innovative ... bestowed its Health Literacy Hero award. In ...
(Date:5/1/2015)... Semler Scientific, Inc. (Nasdaq: SMLR ), ... and markets products that assist healthcare providers in monitoring ... for the first quarter ended March 31, 2015. ... reported continued progress with year over year growth of ... 14%," said Doug Murphy-Chutorian , M.D., chief executive ...
(Date:5/1/2015)... -- Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: AERI ) ... results of the Phase 3 Rocket 1 trail of ... to meet its end points, compelling data from the ... studies. An analyst report on AERI that ... analyst summary, valuation, and recommendation can be viewed by ...
Breaking Medicine Technology:Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... FARMINGDALE, N.Y., Feb. 9, 2011 Misonix, Inc. ... company that designs, manufactures, and markets innovative, therapeutic, ... neurosurgery, laparoscopic surgery, and other surgical and medical ... fiscal quarter and six months ending December 31, ...
... SAN FRANCISCO, Feb. 9, 2011 SYNARC, ... to the pharmaceutical and biotechnology industries, announced today that ... and marketing efforts in support of the company,s rapidly ... Ciaran Cooper, a pioneer in the clinical trials ...
Cached Medicine Technology:Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 2Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 3Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 4Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 5Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 6SYNARC Appoints Ciaran Cooper as Vice President, Business Development 2
... VasoSeal VHD was ... rapidly stop bleeding after ... and radiology procedures. It ... sealing device approved for ...
... collagen hemostat. FirstStop is a non-friable, non-woven ... characteristics. It can easily be cut to ... FirstStop products are not dispersed when wet ... hemostasis is achieved. As the collagen forms ...
InterVascular HemaPatch product line offers the vascular surgeon a range of collagen coated patches in a range of larger sizes angioplasty, or profundaplasty procedures without suture hole bleeding. ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
Medicine Products: